NO20042912L - Anvendelse av anastrozole for behandling av post-menopausale kvinner med tidlig brystkreft - Google Patents

Anvendelse av anastrozole for behandling av post-menopausale kvinner med tidlig brystkreft

Info

Publication number
NO20042912L
NO20042912L NO20042912A NO20042912A NO20042912L NO 20042912 L NO20042912 L NO 20042912L NO 20042912 A NO20042912 A NO 20042912A NO 20042912 A NO20042912 A NO 20042912A NO 20042912 L NO20042912 L NO 20042912L
Authority
NO
Norway
Prior art keywords
breast cancer
anastrozole
post
early breast
treatment
Prior art date
Application number
NO20042912A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Dukes
Paul Plourde
Anthony Rogers
Brent Vose
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042912(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20042912L publication Critical patent/NO20042912L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Treatment Of Metals (AREA)
NO20042912A 2001-12-10 2004-07-09 Anvendelse av anastrozole for behandling av post-menopausale kvinner med tidlig brystkreft NO20042912L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129457.8A GB0129457D0 (en) 2001-12-10 2001-12-10 Method of treatment
PCT/GB2002/005554 WO2003053438A1 (en) 2001-12-10 2002-12-06 Use of anastrozole for the treatment of post-menopausal women having early breast cancer

Publications (1)

Publication Number Publication Date
NO20042912L true NO20042912L (no) 2004-08-25

Family

ID=9927290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042912A NO20042912L (no) 2001-12-10 2004-07-09 Anvendelse av anastrozole for behandling av post-menopausale kvinner med tidlig brystkreft

Country Status (29)

Country Link
US (1) US20050165081A1 (de)
EP (2) EP1997492A1 (de)
JP (2) JP5335173B2 (de)
KR (1) KR100858946B1 (de)
CN (1) CN100408036C (de)
AT (1) ATE406160T1 (de)
AU (1) AU2002347371B2 (de)
BR (1) BR0214798A (de)
CA (1) CA2468965C (de)
CO (1) CO5590926A2 (de)
CY (1) CY1108462T1 (de)
DE (1) DE60228616D1 (de)
DK (1) DK1455781T3 (de)
ES (1) ES2303811T3 (de)
GB (1) GB0129457D0 (de)
HK (1) HK1069335A1 (de)
HU (1) HUP0402023A3 (de)
IL (1) IL162150A0 (de)
IS (1) IS7300A (de)
MX (1) MXPA04005394A (de)
NO (1) NO20042912L (de)
NZ (1) NZ533106A (de)
PL (1) PL369411A1 (de)
PT (1) PT1455781E (de)
RU (1) RU2320339C2 (de)
SI (1) SI1455781T1 (de)
UA (1) UA79443C2 (de)
WO (1) WO2003053438A1 (de)
ZA (1) ZA200404260B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment
WO2005089511A2 (en) * 2004-03-19 2005-09-29 Transform Pharmaceuticals, Inc. Novel pharmaceutical forms, and methods of making and using the same
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN100337625C (zh) * 2004-08-30 2007-09-19 鲁南制药集团股份有限公司 阿那曲唑的分散片剂型
CN1304054C (zh) * 2004-12-29 2007-03-14 山东蓝金生物工程有限公司 一种缓慢释放的抗癌药物组合物
GB0517674D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
GB0517673D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
WO2011130381A1 (en) * 2010-04-13 2011-10-20 Estrocept Diagnostics, Inc. Diagnostic assays for breast cancer treatment and progression
US10201549B2 (en) 2013-06-14 2019-02-12 Professional Compounding Centers Of America (Pcca) Testosterone combined with anastrozole injection solutions
CN103450099B (zh) * 2013-09-06 2015-03-25 杭州华东医药集团新药研究院有限公司 阿那曲唑及其一水合物的新晶型、制备和用途
RU2548722C1 (ru) * 2013-12-06 2015-04-20 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола
DE102014005513B4 (de) 2014-04-15 2018-03-15 Sanoxsys Gmbh Mittel zur Prävention und Therapie von Tumorerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
AR034142A1 (es) * 2000-09-08 2004-02-04 Sloan Kettering Inst Cancer Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment

Also Published As

Publication number Publication date
AU2002347371A1 (en) 2003-07-09
HK1069335A1 (en) 2005-05-20
HUP0402023A3 (en) 2008-08-28
WO2003053438A1 (en) 2003-07-03
DK1455781T3 (da) 2008-11-24
EP1997492A1 (de) 2008-12-03
ZA200404260B (en) 2005-10-26
KR20040066886A (ko) 2004-07-27
GB0129457D0 (en) 2002-01-30
CO5590926A2 (es) 2005-12-30
HUP0402023A2 (hu) 2005-01-28
ES2303811T3 (es) 2009-02-01
US20050165081A1 (en) 2005-07-28
JP5335173B2 (ja) 2013-11-06
CY1108462T1 (el) 2014-04-09
DE60228616D1 (de) 2008-10-09
SI1455781T1 (sl) 2008-12-31
CN100408036C (zh) 2008-08-06
IL162150A0 (en) 2005-11-20
NZ533106A (en) 2008-02-29
CN1630519A (zh) 2005-06-22
AU2002347371B2 (en) 2007-05-10
JP2005516021A (ja) 2005-06-02
EP1455781A1 (de) 2004-09-15
RU2320339C2 (ru) 2008-03-27
CA2468965C (en) 2011-08-30
MXPA04005394A (es) 2005-04-19
JP2011016828A (ja) 2011-01-27
EP1455781B1 (de) 2008-08-27
PT1455781E (pt) 2008-11-03
IS7300A (is) 2004-06-04
ES2303811T1 (es) 2008-09-01
CA2468965A1 (en) 2003-07-03
PL369411A1 (en) 2005-04-18
KR100858946B1 (ko) 2008-09-17
ATE406160T1 (de) 2008-09-15
RU2004121162A (ru) 2005-05-20
BR0214798A (pt) 2004-10-19
UA79443C2 (en) 2007-06-25

Similar Documents

Publication Publication Date Title
HK1069335A1 (en) Use of anastrozole for the treatment of post-menopausal women having early breast cancer
MY127290A (en) New use of flibanserin
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
TR200201442T2 (tr) Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
GB0128108D0 (en) Therapeutic use
IL159887A0 (en) Combination therapy for the treatment of cancer
HUP0301460A2 (hu) Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához
HK1068261A1 (en) Combinations comprisinga selective cyclooxygenase-2 inhibitor
CA2327753A1 (en) Breast cancer treatment support bra
MXPA04004306A (es) Uso de antagonistas del receptor de endotelina para el tratamiento de enfermedades tumorales.
AU2003217397A8 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
EP1201247A3 (de) Behandlung von Tumor-Metastasen und Krebs
MXPA03006412A (es) Metodos para administrar analogos de epotilona para tratamiento de cancer.
RS16804A (en) Use of 4-pyridylmethylphthalazines for cancer treatment
DE69912477D1 (de) Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей
PL376407A1 (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
徐兵河 et al. THE CLINICAL COURSE AND TREATMENT RESULTS OF LUNG METASTASES FROM BREAST CANCER
EP1385497A4 (de) Verfahren zur prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n-dimethylglycin
GB0110908D0 (en) Proreins, genes and their use for diagnosis and treatment of breast cancer
TW527918U (en) Medical chest strap dedicated for breast cancer patient
GB0121818D0 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
NZ516564A (en) Cancer therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application